Liver Transplantation for Cirrhosis and Acute-on-Chronic Liver Failure
This observational study is looking at liver transplantation (LT) in patients with severe liver disease. It aims to understand the best times to consider LT for people with cirrhosis (scarring of the liver) and acute-on-chronic liver failure (ACLF, a sudden worsening of long-term liver disease). Researchers will compare the survival rates after LT in patients with different levels of ACLF, and also look at patients who don't receive a transplant. The study will follow participants for one year. You may be able to join if you are 18 to 80 years old, have liver cirrhosis, and have been hospitalized for a sudden worsening of your liver condition. The study is currently unclear on its recruitment status.
- Study design
- This is an observational study involving 3000 participants. It compares different groups of patients with liver disease.
- What's involved
- Participants will be followed for one year after liver transplantation, or for one year after joining the study if they are not listed for transplant.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one year after liver transplantation or after inclusion in the study.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Liver Transplantation in Patients With CirrHosis and Severe Acute-on-Chronic Liver Failure: iNdications and outComEs
At a glance
Conditions
Where it's being run
106 sites across 45 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
What this trial measures
- Survival1 year
survival